DNAPrint Genomics, Inc.

DNAG · OTC

$0.00 +0.00% (+$0.00)

Piotroski F-Score Weak

3/9

Valuation

N/A

P/FCF N/A

P/E N/A

P/FFO N/A

Growth

N/A

FCF growth N/A

EPS growth N/A

Book val. growth N/A

Profitability

N/A

Op. margin N/A

Gross margin N/A

FCF margin N/A

Quality

N/A

ROA N/A

ROIC N/A

Asset turnover N/A

Debt

N/A

Debt/Assets N/A

Debt/Equity N/A

Net debt/EBITDA N/A

Stability

31 /100

Unstable

Beta 1.53x

Profitable years N/A

Rev. volatility N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o DNAG

Online

Sector

Healthcare

Industry

Biotechnology

CEO

Jatin Patel

Employees

Headquarters

Sarasota

⌘ K

StockBot Live

Tržne razmere Wall Street

Wall Street višje ob upadu cen nafte

Ameriške delnice rastejo ob padcu nafte. S&P 500 +0.60% in Nasdaq +0.80% vodita splošno rast.

Vprašajte o tem

StockBot pozna 80,000+ delnic po vsem svetu